» Articles » PMID: 38792208

Efficacy of Glycyrrhetinic Acid in the Treatment of Acne Vulgaris Based on Network Pharmacology and Experimental Validation

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2024 May 25
PMID 38792208
Authors
Affiliations
Soon will be listed here.
Abstract

Glycyrrhetinic acid (GA) is a saponin compound, isolated from licorice (Glycyrrhiza glabra), which has been wildly explored for its intriguing pharmacological and medicinal effects. GA is a triterpenoid glycoside displaying an array of pharmacological and biological activities, including anti-inflammatory, anti-bacterial, antiviral and antioxidative properties. In this study, we investigated the underlying mechanisms of GA on acne vulgaris through network pharmacology and proteomics. After the intersection of the 154 drug targets and 581 disease targets, 37 therapeutic targets for GA against acne were obtained. A protein-protein interaction (PPI) network analysis highlighted TNF, IL1B, IL6, ESR1, PPARG, NFKB1, STAT3 and TLR4 as key targets of GA against acne, which is further verified by molecular docking. The experimental results showed that GA inhibited lipid synthesis in vitro and in vivo, improved the histopathological damage of skin, prevented mast cell infiltration and decreased the level of pro-inflammatory cytokines, including TNF-α, IL-1β and IL-6. This study indicates that GA may regulate multiple pathways to improve acne symptoms, and the beneficial effects of GA against acne vulgaris might be through the regulation of sebogenesis and inflammatory responses.

Citing Articles

Network pharmacology analysis of the Huangqi-Gancao herb pair reveals quercetin as a therapeutics for allergic rhinitis via the RELA-regulated IFNG/IRF1 axis response.

Deng Y, Shen L, Zhu H, Zhou Y, Hu X Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1597-1612.

PMID: 39133272 PMC: 11825621. DOI: 10.1007/s00210-024-03353-8.

References
1.
Ruan S, Hu Y, Wu W, Du Q, Wang Z, Chen T . Explore the Anti-Acne Mechanism of Licorice Flavonoids Based on Metabonomics and Microbiome. Front Pharmacol. 2022; 13:832088. PMC: 8861462. DOI: 10.3389/fphar.2022.832088. View

2.
Lee S, Kim J, Jeong M, Zouboulis C, Lee S . 11β-hydroxysteroid dehydrogenase type 1 is expressed in human sebaceous glands and regulates glucocorticoid-induced lipid synthesis and toll-like receptor 2 expression in SZ95 sebocytes. Br J Dermatol. 2012; 168(1):47-55. DOI: 10.1111/bjd.12009. View

3.
Shinu P, Gupta G, Sharma M, Khan S, Goyal M, Nair A . Pharmacological Features of 18β-Glycyrrhetinic Acid: A Pentacyclic Triterpenoid of Therapeutic Potential. Plants (Basel). 2023; 12(5). PMC: 10005454. DOI: 10.3390/plants12051086. View

4.
Kistowska M, Gehrke S, Jankovic D, Kerl K, Fettelschoss A, Feldmeyer L . IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo. J Invest Dermatol. 2013; 134(3):677-685. DOI: 10.1038/jid.2013.438. View

5.
Zouboulis C, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S . The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology. 1998; 196(1):21-31. DOI: 10.1159/000017861. View